Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Blumenstein
Bernd Blumenstein, Dortmund DE
| Patent application number | Description | Published |
|---|---|---|
| 20100012680 | DISPENSING DEVICE - A dispensing device for a preferably cosmetic liquid as well as a method for the manufacture thereof are proposed. A lasting and tight joining of two materials is achieved while allowing for simple manufacture by pretreating the surface of the first material by means of plasma treatment or irradiation in a desired joining area in order to form radicals there or to break up the polymer chains of the first material, and by then injecting the second material directly against the first material. Another aspect consists in covering the first material with a second material for joining with another material or component. | 01-21-2010 |
| 20100147898 | DISPENSING DEVICE - The invention relates to a dispensing device, particularly a dispensing head proposed for preferably cosmetic liquid. A simple, tightly closing structure of an outlet valve is achieved in that a valve element is injected onto a wall and/or lies thereon with its entire surface or flat surface when the valve is closed and/or the valve element covers an outlet opening on the flat side. Alternatively or in addition, the valve element is pretensioned into a closed position when the valve is closed. | 06-17-2010 |
Dieter Blumenstein, Uhldingen-Muhlhofen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090258258 | DEVICE AND METHOD FOR OPERATION OF A FUEL CELL - A pressure equalizing system ( | 10-15-2009 |
| 20090258279 | FUEL CELL SYSTEM, IN PARTICULAR, FOR USE ON BOARD A COMMERCIAL AIRCRAFT OR MOTOR VEHICLE - For operation on board a commercial aircraft ( | 10-15-2009 |
Felix Blumenstein, Hessisch Lichtenau DE
| Patent application number | Description | Published |
|---|---|---|
| 20090046491 | Inverter - An inverter ( | 02-19-2009 |
| 20090046492 | Inverter - An inverter ( | 02-19-2009 |
Lars Blumenstein, Frankfurt Am Main DE
| Patent application number | Description | Published |
|---|---|---|
| 20120083494 | NOVEL TRIAZOLE DERIVATIVES WITH IMPROVED RECEPTOR ACTIVITY AND BIOAVAILABILITY PROPERTIES AS GHRELIN ANTAGONISTS OF GROWTH HORMONE SECRETAGOGUE RECEPTORS - The present invention provides novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin analogue ligands of growth hormone secretagogue receptors according to formula (I) that are useful in the treatment or prophylaxis of physiological and/or pathophysiological conditions in mammals, preferably humans, that are mediated by GHS receptors. The present invention further provides GHS receptor antagonists and agonists that can be used for modulation of these receptors and are useful for treating above conditions, in particular alcohol disorder, drug abuse, growth retardation, cachexia, short-, medium-, and/or long term regulation of energy balance, short-, medium-, and/or long term regulation (stimulation and/or inhibition) of food intake, intake of rewarding food, adipogenesis, adiposity and/or obesity, body weight gain and/or reduction, diabetes, diabetes type I, diabetes type II, tumor cell proliferation, inflammation, inflammatory effects, gastric postoperative ileus, postoperative ileus and/or gastrectomy (ghrelin replacement therapy). | 04-05-2012 |
Sara Blumenstein, Ramat Gan IL
| Patent application number | Description | Published |
|---|---|---|
| 20110053841 | N-TERMINAL FGF VARIANTS HAVING INCREASED RECEPTOR SELECTIVITY AND USES THEREOF - The present invention relates to the design, manufacture and use of fibroblast growth factor (FGF) polypeptides having improved receptor specificity. In particular, the invention relates to isolated FGF2 and FGF4 polypeptides that include a truncated N-terminus and optionally N-terminal amino acid substitutions. The present invention provides polypeptides, nucleic acids encoding the polypeptides, compositions of the same and methods for use thereof. | 03-03-2011 |
| 20110294134 | METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER - Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed. | 12-01-2011 |